✦ LIBER ✦

Her-2/neuand Topoisomerase iiα in Breast Cancer

✍ Scribed by Tero A.H. Järvinen; Edison T. Liu

Book ID: 110432422
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 188 KB
Volume: 78
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1023077507295

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topoisomerase IIα Expression in Breast C

Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome Variables

✍ Depowski, Peter L.; Rosenthal, Seth I.; Brien, Thomas P.; Stylos, Scott; Johnson 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 512 KB

Predictive value of apoptosis, prolifera

Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIα for anthracycline chemotherapy in locally advanced breast cancer

✍ G. Arpino; D. R. Ciocca; H. Weiss; D. C. Allred; P. Daguerre; L. Vargas-Roig; M. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 202 KB

Characterization of topoisomerase IIα ge

Characterization of topoisomerase IIα gene amplification and deletion in breast cancer

✍ Tero A.H. Järvinen; Minna Tanner; Maarit Bärlund; Åke Borg; Jorma Isola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Topoisomerase II␣ (TOP2A) is a key enzyme in DNA replication and a molecular target for many important anticancer drugs. TOP2A is amplified or deleted together with amplification of the closely located ERBB2/HER-2/neu oncogene in breast cancer. We characterized the copy number aberrations of TOP2A a

DNA topoisomerase IIα expression and the

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer

✍ MacGrogan, G; Rudolph, P; Mascarel, I de; Mauriac, L; Durand, M; Avril, A; Dilhu 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 154 KB

Topoisomerase II alpha amplification may

Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer

✍ Edurne Arriola; Socorro Maria Rodriguez-Pinilla; Maryou B. K. Lambros; Robin L. 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 321 KB

Topoisomerase IIα content and topoisomer

Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines

✍ K. Yamazaki; Hiroshi Isobe; Tarou Hanada; Tomoko Betsuyaku; Atsushi Hasegawa; No 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 332 KB